Area of research
Infectious Diseases · Transplantation
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Transplantation: Methods and Outcomes.
RSV Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.
International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients.
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY).
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.
Estimated Median Waiting Time for Organ Procurement and Transplantation Network Human Immunodeficiency Virus Organ Policy Equity Act Variance Kidney Candidates: A Propensity Score Matched Analysis.
Deceased Donor Infectious Diseases Testing and Antimicrobial Use: Surveys of Organ Procurement Organizations and Transplant Professionals.
Measles and Solid Organ Transplantation: Diagnosis, Treatment, and Prevention.
Antiviral Trials-Navigating the Shifting Sands of a Pandemic.
Hepatitis B Virus NAT Positive Donors in Non-Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor-Derived Infection.
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
"They paged me what?": A transplant infectious disease guide to donor calls.
When you need to dive in the deep end-Transplanting SARS-CoV-2 PCR+ recipients.
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV.
Donor‐derived tuberculosis among solid organ transplant recipients in the United States—2008 to 2018
Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.
Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors?
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients
COVID-19 vaccination in our transplant recipients: The time is now
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy.
Rapid test to assess the escape of SARS-CoV-2 variants of concern.
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States
Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee.
Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia.